Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/projects/1124-a-randomized-open-label-phase-3-study-of-tarlatamab-compared-with-standard-of-care-in-subjects-with-relapsed-small-cell-lung-cancer-after-platinum-based-first-line-chemotherapy-dellphi-304/publications